San Diego – based Empirico is a drug discovery company employing customized data models and algorithms, as well as a huge dataset of health information from millions of individuals, to uncover causal connections between genes, proteins, and clinical outcomes and find new genetically validated drug targets. The Empirico Precision Insights Platform helps the company’s scientists generate, interrogate, and prioritize hypotheses about the genetic variants behind health risks and possible ways to interfere with the mechanisms of disease.
News & Insights
Explore Companies
Nilo Therapeutics
Mapping the brain-body axis to achieve proper immune balance
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors